Rezolute, Inc.
RZLT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001509261
No open-market purchases or sales by Rezolute, Inc. insiders were filed in the last 90 days; 144 institutions reported holding it in 13F filings for Q2 2026, worth $450.3M in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in Rezolute, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 23
- +9 vs. Q3 2021
- Shares held
- 7.53M
- +5.16M (+217.3%) vs. Q3 2021
- Total value
- $36.0M
- +$18.3M (+103.9%) vs. Q3 2021
- New holders
- 11
- 7 more added
- Sold out
- 2
- 3 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RZLT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 144 | $450.3M |
| Q1 2026 | 125 | $263.2M |
| Q4 2025 | 122 | $213.4M |
| Q3 2025 | 116 | $817.1M |
| Q2 2025 | 92 | $347.5M |
| Q1 2025 | 77 | $130.6M |
| Q4 2024 | 71 | $211.7M |
| Q3 2024 | 59 | $186.9M |
| Q2 2024 | 52 | $170.0M |
| Q1 2024 | 33 | $69.0M |
| Q4 2023 | 32 | $28.7M |
| Q3 2023 | 30 | $31.5M |
| Q2 2023 | 29 | $48.0M |
| Q1 2023 | 32 | $46.5M |
| Q4 2022 | 34 | $50.6M |
| Q3 2022 | 33 | $67.0M |
| Q2 2022 | 35 | $79.2M |
| Q1 2022 | 21 | $24.0M |
| Q4 2021 | 23 | $36.0M |
| Q3 2021 | 14 | $17.6M |
| Q2 2021 | 12 | $31.6M |
| Q1 2021 | 11 | $17.5M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Rezolute, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Federated Hermes, Inc. | 3,189,222 | $15.2M | 0.03% | +1,977,100+163.1% | Added |
| Caxton Corp | 1,193,473 | $5.71M | 4.66% | +769,230+181.3% | Added |
| Stonepine Capital Management, LLC | 808,405 | $3.86M | 1.77% | +808,405 | New |
| Vanguard Group Inc | 333,239 | $1.59M | 0.00% | +200,872+151.8% | Added |
| Citadel Advisors LLC | 308,287 | $1.47M | 0.00% | −1,699−0.5% | Reduced |
| Velan Capital Investment Management LP | 300,000 | $1.43M | 1.20% | +300,000 | New |
| AIGH Capital Management LLC | 265,181 | $1.27M | 0.40% | +265,181 | New |
| Altium Capital Management LP | 230,000 | $1.10M | 0.31% | +230,000 | New |
| J. Goldman & Co LP | 202,500 | $968.0K | 0.09% | +202,500 | New |
| BVF Inc | 190,815 | $912.0K | 0.03% | 00.0% | Unchanged |
| Maven Securities LTD | 115,758 | $553.0K | 0.07% | +115,758 | New |
| ExodusPoint Capital Management, LP | 104,053 | $497.0K | 0.01% | +104,053 | New |
| Sender Co & Partners, Inc. | 81,849 | $391.0K | 0.25% | +81,849 | New |
| Worth Venture Partners, LLC | 60,718 | $290.0K | 0.14% | +60,718 | New |
| Northern Trust Corp | 52,293 | $250.0K | 0.00% | +16,394+45.7% | Added |
| Boothbay Fund Management, LLC | 36,922 | $176.0K | 0.01% | +36,922 | New |
| Millennium Management LLC | 20,571 | $98.0K | 0.00% | −15,141−42.4% | Reduced |
| BlackRock Inc. | 19,583 | $94.0K | 0.00% | +7,413+60.9% | Added |
| Shay Capital LLC | 11,780 | $56.0K | 0.02% | +11,780 | New |
| UBS Group AG | 4,308 | $21.0K | 0.00% | +637+17.4% | Added |
| The PNC Financial Services Group, Inc. | 750 | $4.00K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 21 | $0 | 0.00% | −501−96.0% | Reduced |
| Wells Fargo & Company | 71 | $0 | 0.00% | +43+153.6% | Added |
| Oppenheimer & Co Inc | 0 | $0 | 0.00% | −12,281−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −2,678−100.0% | Sold out |